Update on medical expulsive therapy for distal ureteral stones: Beyond alpha-blockers

Auteurs-es

  • Derek Bos McMaster University
  • Anil Kapoor McMaster University

DOI :

https://doi.org/10.5489/cuaj.2472

Mots-clés :

urolithiasis, medical expulsive therapy, alpha-blockers, ureteric stones

Résumé

Medical expulsive therapy (MET) has been described as an effective conservative treatment option in the initial management of small distal ureteral stones. Therapies that have been investigated include alpha-blockers, calcium channel blockers, corticosteroids, and most recently phosphodiesterase-5 inhibitors (PDE5) inhibitors. While alpha-blockers are currently the only recommended monotherapy, corticosteroids have received increased attention as a potential useful adjunct in the medical management of distal stones. PDE5 inhibitors are a novel treatment alternative, requiring further investigation. This review provides an overview of recent MET best practices, with a focus on novel therapies beyond alpha blockers.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Bibliographies de l'auteur-e

Derek Bos, McMaster University

McMaster Urology Resident

Anil Kapoor, McMaster University

Professor of Surgery (Urology), McMaster University

Téléchargements

Publié-e

2014-12-15

Comment citer

Bos, D., & Kapoor, A. (2014). Update on medical expulsive therapy for distal ureteral stones: Beyond alpha-blockers. Canadian Urological Association Journal, 8(11-12), 442–5. https://doi.org/10.5489/cuaj.2472